Chemical Week Magazine :: Specialty Chemicals
Wacker biologics acquisition
6:53 AM MST | November 22, 2013
Wacker has announced plans to acquire a production site for bioengineered pharmaceutical proteins, or biologics, from BioNet Ventures. The deal covers Wackerâ€™s acquisition of Scil Proteins Production, including the patent portfolio, at the Scil site at Halle, Germany. The transaction is expected to close early next year. Wacker will continue with existing customer partnerships, which Scil Proteins Production already has, and will retain Scilâ€™s staff. Scil Proteins Production, founded in 2005, has 80 employees and operates a fermenter at Halle, with capacity...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee